Author

Hager Salah

Institution: King Hamad University Hospital

Observed institution: King Hamad University Hospital

ORCID: 0000-0002-5851-0260

Observed ORCID: 0000-0002-5851-0260

OpenAlex ID: A5049709352

Challenges experienced during pharmacy automation and robotics implementation in JCI accredited hospital in the Arabian Gulf area: FMEA analysis-qualitative approach

2023 · May Hassan ElLithy, Omar Alsamani, et al. · Saudi Pharmaceutical Journal · 26

COVID-19′s Psychological Impact on Chronic Disease Patients Seeking Medical Care

2023 · Hager Salah, AL Shaimaa Ibrahim Rabie, et al. · Healthcare · 19

COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers’ Perceptions

2023 · Hager Salah, Israa Sinan, et al. · Vaccines · 10

Benchmarking of medication incidents reporting and medication error rates in a JCI accredited university teaching hospital at a GCC country

2023 · May Hassan ElLithy, Hager Salah, et al. · Saudi Pharmaceutical Journal · 8

Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection

2023 · Al Shaimaa Ibrahim Rabie, Hager Salah, et al. · Healthcare · 8

Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic metastatic breast cancer female patients: a randomized controlled trial

2025 · Hager Salah, Hoda Rabea, et al. · Cancer Chemotherapy and Pharmacology · 4

Efficacy and Safety of Duloxetine with Gabapentin or Amitriptyline Versus Duloxetine Monotherapy in Chemotherapy-Induced Peripheral Neuropathy: Randomized Controlled Trial

2026 · Hager Salah, Ahmed Hassan Shaaban, et al. · Pharmaceuticals · 3

Additive Value of Pyridostigmine to Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia: A Randomized Controlled Trial

2025 · Ahmed G. Mohamed, Hany F. Badawy, et al. · Journal of Clinical Medicine · 1

Pharmaceutical services department strategies and patient perception to maintain healthcare services during COVID-19 crisis

2022 · Hager Salah, Omar Alsamani, et al. · Saudi Pharmaceutical Journal · 1

Longitudinal patient-reported outcomes and predictors of improvement in chemotherapy-induced peripheral neuropathy a secondary analysis of a randomized trial

2026 · Hager Salah, Ahmed Hassan Shaaban, et al. · Frontiers in Pharmacology

Works count: 10

Citation count: 80

H-index: 5

I10-index: 3